Recruiting NA Gastroparesis

Compares treatment options for Gastroparesis

Official title G-POEM vs PEG-J in Gastroparesis Patients

ClinicalTrials.gov ID: NCT06372132

What this study is testing

What it's testing
Study design: A randomized non-blinded controlled clinical trial with two study arms (G-POEM and PEG-J). Treatment success is measured using the GCSI at baseline before intervention and six months after intervention with a possible cross-over after six months of follow-up.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Patients with GP
  • 13C octanoic acid test or gastric scintigraphy (minimal 4-hour measurement) within the past twelve months
  • 18 years old

You likely can't join if

  • \< 18 years old
  • Medical history of stomach surgery in which resection of antrum and/ or pylorus took place
  • Medical history of surgical or laparoscopic pyloromyotomy
  • Gastric bypass
  • Current opioid use
  • Pregnancy

The study team makes the final eligibility decision.

Where it's taking place

  • Maastricht, Zuid-Limburg, Netherlands

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Maastricht, Zuid-Limburg, Netherlands. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.